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Synopsis Two lamprey glycroprotein hormone receptors (lGpH-R I and II) highly similar with gnathostome GpH-Rs
were cloned from sea lamprey testes and thyroid, respectively. Vertebrate glycoprotein protein receptors have a large
extracellular domain (ED) containing a leu rich domain (LRD) linked to a rhodopsin-like transmembrane domain
(TMD) through a highly divergent linker region (signal specificity domain, SSD or ‘hinge’ region) and a third major
segment, the intracellular domain. To determine the potential roles of the different domains in the activation of the
receptor following ligand-receptor binding, functional assays were performed on lGpH-R I/rat luteinizing hormone (LH)-R
domain swapped chimeric receptors. These results show that the functional roles of the lamprey glycoprotein-receptor I
(lGpH-R I) domains are conserved compared with its Gnathostome homologs. The ability of different glycoprotein
hormones to activate chimeric lamprey/rat receptors suggests that the selectivity of the GpH-Rs in respect to their
ligands is not controlled exclusively by a single domain but is the result of specific interactions between domains.
We hypothesize that these interactions were refined during millions of years of co-evolution of the receptors with their
cognate ligands under particular intramolecular, intermolecular and physiological constraints.
Introduction
The thyroid and gonadal steroid hormone secretions
as well as development of the thyroid and gonads
in vertebrates are controlled by three closely related
glycoprotein hormone (GpH)/glycoprotein hormone
receptor (GpH-R) tandems. Thyrotropin hormone
(TSH) is released from anterior pituitary thyrotrophs
and binds to the thyrotropin hormone receptor
(TSH-R) in the thyroid modulating the gene expres-
sion in this tissue (Szkudlinski et al. 2002). Similarly,
the pituitary follicle stimulating hormone (FSH)
binds to the cognate receptor (FSH-R) expressed
on the membrane of the testicular Sertoli or ovarian
granulosa cells (FSH-R) (Simoni et al. 1997). The
expression of the receptor for the pituitary luteiniz-
ing hormone (LH-R) was detected predominantly in
the Leydig cells of the testes and in theca, interstitial,
granulosa, and luteal cells of the ovary (Dufau 1998).
Glycoprotein hormones have a similar molecular or-
ganization, being dimeric proteins with one subunit
(alpha) present in all GpHs, while the beta subunit is
specific to each hormone. Correspondingly, their re-
ceptors are highly similar, having a large extracellular
domain (ED) containing a leu rich domain (LRD)
linked to a rhodopsin-like transmembrane domain
(TMD) through a highly divergent linker region (sig-
nal specificity domain, SSD or ‘hinge’ region). The
third major segment is the intracellular domain (ID),
which shows a lower similarity score.
The physiology of the hypothalamic–pituitary–
thyroid (HPT) and hypothalamic–pituitary–gonadal
(HPG) axes and in this context the interactions of
the glycoprotein hormones with their receptors have
been extensively studied in vertebrates, particularly in
mammals. However, little is known about the evolu-
tionary origin of this endocrine control system. It is
widely accepted that all glycoprotein hormones, as
well as their receptors, are descendants of common
molecular ancestors and that their duplication and
divergent sub-functionalization started before the di-
vergence of the vertebrates. In recent years, a number
of hormones and receptors from this group have
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been identified and described in some early-evolved
vertebrate lineages, particularly in fish (Freamat et al.
2006; Freamat and Sower 2008a; reviewed by
Freamat and Sower 2008b; MacKenzie et al. 2009;
Levavi-Sivan et al. 2010). This opened a perspective
on the remarkable degree of conservation of these
hormone/receptor systems across the different
branches of vertebrates. The search for the patterns
of endocrine control similar to HPT/G axes in the
closest relatives of vertebrates, the Protochordates,
has provided important clues, but no definitive
answer, to the question of how a high physiological
specificity has emerged from interaction of molecular
species which show otherwise close functional and
structural characteristics. Nine forms of gonadotro-
pin releasing hormone (GnRH) were identified in
different species of tunicates (Di Fiore et al. 2000;
Adams et al. 2003). It was reported that mammalian
GnRH is able to induce steroid synthesis in isolated
Ciona intestinalis gonads (Di Fiore et al. 2000) and
synthetic forms of urochordate GnRH induced release
of gametes when injected into adult C. intestinalis
(Adams et al. 2003). Although protochordates lack
thyroid follicles, the presence of thyroid-like hor-
mones has been described in blood, endostyle, and
tunic of adult urochordates as well as in their larvae
(Sherwood et al. 2005). To date, no evidence has
been found for the presence of gonadotropin or
thyrotropin-like hormones in urochordates
(Sherwood et al. 2006). The closest relative of the
glycoprotein hormone receptors annotated or detect-
able by Blast searches with GpH-R sequence queries
in the C. intestinalis genome (http://ge-
nome.jgipsf.org/Cioin2/Cioin2.hhome.html) was a
homolog of the relaxin receptor LGR7 (data not
shown).
In cephalochordates, mammalian GnRH (type 1)
peptide sequence was identified using mass spectro-
metry in European amphioxus (Chambery et al.
2009), although genomic searches to date have not
yielded a GnRH coding sequence (Tello and
Sherwood, 2009). Tello and Sherwood (2009) have
identified and performed functional studies on four
GnRH receptor sequences identified from the amphi-
oxus genome; two of the four GnRH receptors re-
sponded to type 1 and 2 GnRHs suggesting that
these receptors are prototypes for vertebrate GnRH
receptors. In earlier studies, immunoreactive (ir)-LH
had been shown in these protochordates (Nozaki
and Gorbman 1992; Fang et al. 2001). More recently,
the beta subunit of the glycoprotein hormone,
AmpGPB5, was cloned in amphioxus (Tando and
Kubowawa 2009). However, there has been no evi-
dence for the presence of a glycoprotein hormone
receptor in these organisms. These data suggest a
possible direct relationship between neuroendocrine
factors (GnRH, TRH) and secretion of thyroid-like
or gonadal-steroid-like hormones from peripheral
glandular tissues and/or activation of gametogenesis
or thyroid-like functions in these primitive organ-
isms (Gorbman and Sower, 2003; Sower et al.
2009; Tando and Kuobowa 2009). Thus, the available
evidence offers little support for the existence of a
pituitary-like gland acting as a relay between the brain
and peripheral hormone systems prior to the emer-
gence of vertebrates. A projection of the brain
contacting the Hatschek’s pit in amphioxus was de-
scribed as a possible predecessor of the hypothala-
mic-pituitary system in vertebrates (Gorbman et al.
1999; however, genome analyses indicate that
ampioxus probably lacks homologs of several key
pituitary hormones (Holland et al. 2008). From
this perspective, the appearance of the hypothalamic–
pituitary/thyroid/gonadal axes in vertebrates coin-
cides with the interpolation of a new level
(Hartenstein 2006; Sower et al. 2009) in the respec-
tive neural-peripheral hierarchy of gland control: the
glycoprotein hormone/glycoprotein hormone recep-
tor, concomitantly with the development of special-
ized glandular tissues (the pituitary).
In mammals, the GpH/GpH-R system exhibits two
characteristics tightly related to their proper function
under normal physiological conditions: the specificity of
their temporal and tissue expression profiles and selec-
tivity in their interaction with the ligands (Simoni et al.
1997; Ascoli 2005; Costagliola et al. 2005; Farid and
Szkudlinski 2004). These characteristics have evolved
during divergent evolution of the ancestral duplicated
genes that were inherently neither specific in their ex-
pression nor selective in their ligand affinities.
The sea lamprey and hagfish are the only extant
representatives of the jawless organisms (Agnatha).
It was estimated, based on DNA data (Donoghue
and Purnell 2005), that the cyclostomes (lamprey
and hagfishes) diverged from the ancestral agnathans
during the early Paleozoic era, 535–462 million years
ago. Moreover, the fossil records suggest that the
lamprey lineage diverged directly from the ancestral
extinct agnathans (Gess et al. 2006; Janvier 2006).
This makes this species an excellent object of study
for understanding the endocrinology of the ancestors
of present-day vertebrates.
Two novel glycoprotein hormone receptors were
identified and described in lamprey (Freamat et al.
2006; Freamat and Sower 2008a) as well as the beta
chain of a novel glycoprotein hormone (Sower et al.
2006). This is the only GpH detected so far in lam-
prey using either molecular biological methods or
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extensive screening of the lamprey genome se-
quencing data. Molecular phylogenetic relationships
between vertebrate GpH beta chains shows the lam-
prey sequence far removed from the beta TSH, FSH,
and LH clade, acting as an outgroup for all verte-
brate glycoprotein hormone beta subunits (Sower
et al. 2006). The receptor sequences on the other
hand are clustered as a sister group of the thyrotro-
pin receptors when the molecular phylogenetic rela-
tionships are derived using the whole coding
sequence data. A different picture was observed
when individual functional domains were used in
phylogenetic analysis (Freamat and Sower 2008a,
2008b). The ED tree exhibits the same topology as
the full coding sequence. The TMD suggests a phy-
logeny where the lGpH-R I acts as an outgroup to
vertebrate GpH-Rs while the lGpH-R II keeps its
monophyletic position with the TSH-R sequences
(Freamat and Sower 2008a, 2008b). We hypothesize
that lamprey GpH-R I and II are homologs of
later-evolved vertebrate LH, FSH, and TSH receptors,
descending from a common ancestor which was
TSH-R-like (Freamat et al. 2006; Freamat and
Sower 2008a). The difference in the phylogenetic sig-
nals for different domains is likely due to the func-
tional constraints acting differentially at the level of
different segments of the receptor. The ED tree to-
pology reflects a similar pattern of substitution due
to the interaction with a single ligand while the TMD
is more significant in respect to the actual evolution-
ary relationships between members of the GpH-R
subfamily (Castresana 2000). In this article, function-
al assays were performed on lGpH-R I/rat LH-R
domain swapped chimeric receptors testing various




LH-R receptor was a gift from Dr William Moyle.
Lamprey glycoprotein hormone receptor I was ob-
tained through molecular cloning from lamprey
testes tissue (Freamat et al. 2006).
Hormones
Ovine LH and ovine TSH were obtained from
National Hormone & Peptide Program (NHPP).
Human FSH, human CG, and the preg-
nant mare serum gonadotropin (PMSG) were pur-
chased from Sigma (Sigma-Aldrich Corporation,
St. Louis, MO).
Preparationof the chimeric lamprey/rat glycoprotein
hormone receptor chimeric constructs
LH-R receptor was subcloned in pcDNA3.1/V5-His
TOPO (Invitrogen, Carlsbad, CA). The lamprey
GpH-R I and rat LH-R DNA fragments were com-
bined in chimeric functional receptors using the
general SOE-PCR (splicing by overlap extension)
methodology (Fig. 1). The method or variants of
this method have been described by different authors
and applied to a wide range of molecules (Horton
et al. 1990; Yang and Zwieb 2001; Hobert 2002;
Heckman and Pease 2007). The two up- and
down-stream receptor fragments intended to be
spliced together were first amplified with gene-
specific primers and universal primers (T7 and
BGH, respectively). The 30 reverse primer for the
upstream fragment was usually chosen as a mutagen-
ic primer, containing at its 50 end a region comple-
mentary to the 50 end of the downstream fragment.
The amplifications were done using the Phusion(r)
high fidelity polymerase from Finnzymes
(Finnzymes/NEB, Ipswich, MA).
Typical amplification conditions at this step in-
cluded an initial denaturation at 988C for 3 min fol-
lowed by cycling with denaturation step at 988C for
30 s, annealing 688C 10 s and extension 30 s at 728C,
repeated 40 times; the final extension was performed
for 10 min at 728C. The amplification products were
then purified by gel electrophoresis and their approx-
imate amount estimated by densitometry. The PCR
splicing step was conducted in two phases. In the
first phase, the receptor fragments were added to
the Phusion(r) master mix in amounts adjusted to
ensure an approximate 1:1 molar ratio between
them, and then run through 10 cycles amplification
with denaturation step 30 s at 988C, annealing 10 s at
608C and extension 30 s at 728C. In the second
phase, primers designed against the 50 end of the
upstream fragment and 30 end of the downstream
fragment were added to the reaction to a final con-
centration of 0.2 mM. The same program with an-
nealing temperature increased to 658C was then
run for 35 cycles. The 50 and 30 primers were de-
signed to include a Kpn I restriction enzyme recog-
nition site and an Age I recognition site, respectively,
to allow subcloning of the full-length hybrid recep-
tor. The 50 primers also included the Kozak consen-
sus for expression in eukaryotic cells.
After amplification, the PCR product was checked
on agarose gel (not shown). Usually the spliced
product was easy to recognize and isolate, based on
its size compared with the expected total size of the
construct. After purification from the gel fragments,
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the chimeric receptors were digested with Kpn I/Age
I restriction enzymes (5 IU/25 ml reaction, o/n) and
ligated into the Kpn I/Age I linearized pcDNA3.1/
V5-His TOPO eukaryotic expression vector and
transfected into the TOP10 (Invitrogen, Carlsbad,
CA) cells. The plasmids were prepared for transfec-
tion by miniprep (Wizard DNA Preparation System,
Promega Corp., Madison, WI), resuspended in en-
dotoxin free TE buffer and verified by Kpn I/Age I
restriction digest. The amount and quality of plasmid
DNA was estimated by measurements of optical den-
sity at 260 and 280 nm.
Concentrations of plasmids in the stock solutions
used for transfection were adjusted at the same value
based on their OD concentrations and on agarose gel
densitometric measurements of restriction digest
products. The pCF3CF2 and pCF1CF4, containing
all the lamprey/rat inter-domain junctions were ver-
ified by sequencing (SeqWright, Houston, TX) in
order to validate the experimental methodology for
construction of chimeric receptors, using lamprey
GpH-R I gene specific and universal (T7 and BGH)
primers.
The procedure for maintenance and transfection
of COS-7 cell cultures
We followed the same protocols as described pre-
viously (Freamat et al. 2006; Freamat and Sower
2008a).
The cAMP-dependent signal-transduction assay
The experimental protocol for the functional assays
of cAMP-dependent signal-transduction activation
by membrane receptors using the Secreted Alkaline
Phosphatase (SEAP) reporter system was described in
Freamat and Sower (2008b). Briefly, the day before
transfection the COS-7cultures were grown in T75
flasks in CO2 (5%) humidified incubator in DMEM
with 10% FBS and were cut with 2 ml trypsin, resus-
pended in the same medium at 4 105 cells/ml and
plated on 6 or 3.5 cm petri dishes or in 12-well plates,
depending on the design of the experiment. The next
day, 3 h before transfection, the medium was replaced
with fresh DMEM 10% FBS then co-transfected with
receptor construct/reporter plasmid mixtures at a
constant receptor:reporter mass ratio of 1:7 using
the Lipofectamine 2000 transfection reagent following
the manufacturers’ (Invitrogen) instructions. The
next day, the cells were detached with Trypsin, resus-
pended at 5 105 cells/ml count, plated on 96-well
plates at 100ml/well and returned in the CO2 incuba-
tor over night. Different layouts for the placement of
the constructs on the plate were used in order to
minimize the systematic errors associated with the
position on the plate. In the next step, the culture
medium was removed, cells washed with serum-free
DMEM, overlayed with 100 ml serum-free DMEM
and incubated over night. Different concentrations
of hormones (stimulation media) were prepared in
Fig. 1 Preparation of chimeric receptors by splicing by overlap extension (SOE-PCR). The figure shows an example of application of
the procedure at the level of the rat LRD/lamprey SSD junction.
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a base buffer containing phenol-red-free DMEM,
1 mg/ml BSA and 0.2 mM IBMX for all samples.
The serum-free DMEM was carefully aspirated
using a multichannel pipette and immediately
replaced with 100 ml of the stimulation medium and
returned in the CO2 incubator for overnight incuba-
tion. The assay for SEAP activity in the culture
medium was started with centrifugation of the cul-
ture plates and transfer of the medium to 96 new well
plates which were incubated subsequently at 658C for
20 min to inhibit the intrinsic alkaline phosphatase
activity. The culture medium was then mixed with
2 SEAP reaction buffer (2 M diethanolamine/HCl
DEA, 1 mM MgCl2, pH¼ 9.8) containing 18 mM
paranitrophenylphosphate (pNPP) chromogenic al-
kaline phosphatase substrate and immediately trans-
ferred to the plate reader (BioTek Inc., Winooski,
VT) set at 405 nm for measuring the initial point in
the progress curve. The optical density measurements
were then taken at various intervals of time, increas-
ing from a higher frequency of around 10 min in the
first hour of incubation to 6 h over a period of 24 h.
The absorbance data was immediately saved into a
text file and the automatically inserted timestamps
were used to construct the SEAP reaction progression
curves.
Experimental data analysis
The alkaline phosphatase activity (initial rate) is a
measure of the relative impact of different trans-
fected recombinant proteins and/or treatments on
the cAMP-dependent signal-transduction pathway.
Initial reaction rates were derived from the raw OD
versus time progress curves in two steps. In the first
step the parameters of an empirical function describ-
ing a saturation kinetics [Equation (1), Amax, K
empirical parameters, t is time] were estimated by
non-linear regression. The initial estimates of the pa-
rameters were obtained by linear regression on the
first points of the curve (usually corresponding to a
reaction time of52 h). The initial rates (S) were then
calculated using the analytical expression for the first
derivative of the saturation function using the pa-
rameters derived from regression [Equation (2)].
The initial rate for each experimental sample is the
sum of the contributions of three processes
[Equation (3)]: (i) the basal accumulation of cAMP
due to the inhibition of the phosphodiesterase by
IBMX (Sbasal), (ii) the accumulation of cAMP due
to the constitutive activity of the receptor construct
(Sconstit), and (iii) the accumulation of cAMP due to
the activation of the receptor construct in response
to the treatment to which the culture was exposed
(hormone or forskolin) Streat. The value for SEAP
activity determined in the culture media for the con-
centration of ligand equal to zero (S0) represents the
sum between the basal value (Sbasal) and the effect of
the constitutive activity of the receptor constructs
(Sconstit) [Equation (5)]. The values of Sbasal were
estimated experimentally as the enzyme activity in
the medium samples obtained from cultures trans-
fected with the blank vector (pcDNA3.1/V5-His
TOPO) [Equation (6)].
f xð Þ ¼ Amax  ð1 expðK  tÞÞ, ð1Þ
S ¼ f 0 0ð Þ ¼ Amax  K ; ð2Þ
Stotal ¼ Sbasal þ Sconstit þ Streat, ð3Þ
StotalFsk ¼ Sbasal þ Sconstit þ SfskðforskolinÞ, ð4Þ
S0 ¼ Sbasal þ Sconstit dose ¼ 0ð Þ, ð5Þ
Sbasal ¼ Sblank pcDNA3:1
 
, ð6Þ
%Sconstit ¼ 100  ðS0  SblankÞðStotalFsk  S0Þ , ð7Þ
%S ¼ 100  ðStotal  S0ÞðStotalFsk  S0Þ : ð8Þ
Differences in means on the dose/response curves
were tested using one-way ANOVA (R/oneway.test)
and pairwise comparison of means was carried out
using Welch two sample t-test (R/t.test). All numer-
ical values are reported as means SEM calculated
from experimental outcomes of at least two different
transfections with duplicate treatment samples (dose/
response data) or at least five different transfections
in duplicate (constitutive activity data).
Calculations and data plots were done in the R
(http://www.r-project.org/; Ihaka and Gentleman
1996) environment; the graphic files were subse-
quently edited in the inkscape SVG editor (http://
www.inkscape.org/) in order to include the supple-
mentary information about the constructs and li-
gands used.
Results
The lamprey lGpH-R I/rat LH-R chimeric
constructs
Figure 2 shows a diagrammatic representation of the
receptor constructs prepared and used in this study.
They are grouped in six series, series A contains
domain-swapped constructs downstream of a rat
signal peptide; series B contains the same constructs
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Fig. 2 Diagram of the chimeric rat LH-R/lamprey GpH-R I chimeric receptors. The systematic interchange between rat and lamprey
GpH-R homologous segments followed an experimental scheme comprised of three steps. In the first step (panels A and B) the target
of recombination were the major structural domains of the two receptors. Group A contains the chimeras built downstream the rat
signal peptide while the Group B have the lamprey signal peptide as common characteristic. In the next step (C and D), the chimeras of
the group A and the native rat LH-R were modified by insertion of a FLAG epitope downstream their rat signal peptide. The third step
in panels E and F involved changes of the signal specificity domain (SSD) of the receptors of the groups C and D, respectively. The
chimeras of the group E and F differ by the type of their LRD (lamprey GpH-R I in group E, rat LH-R in group F).
Fig. 3 Effect of oLH and oTSH on cAMP signal-transduction activation by rat/lamprey chimeric receptors series A and B (Fig. 2) in
COS-7 cells.
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with rat signal peptide replaced by lamprey signal
peptide. These first two chimeric receptor sets lack
the FLAG tag and were used for cAMP signal trans-
duction assays using two concentrations of ovine LH
and ovine TSH as stimuli. The purpose of the exper-
iments involving these constructs was to test for the
possible effect of the signal peptide on the capability
of cells transfected with these constructs to respond
to hormone stimulation and to obtain a preliminary
estimate of the effect of gonadotropins versus thyro-
tropin. Series C and D were obtained using the con-
structs of the series A as starting material; therefore
all of them have the rat signal peptide upstream
to the chimeric receptors. This prevents differential
expression levels of chimeras due to differences
in the processing of lamprey versus rat signal pep-
tide containing precursors. The FLAG epitope
(DYKDDDDK) sequence (corresponding to the
GACTACAAGGACGATGACGATAAG oligo) was in-
serted downstream from the rat signal peptide, at the
N-terminal end of the mature peptide. The presence
of the FLAG tag allows usage of commercial
anti-FLAG antibodies for detection of the protein
either on the cell surface by a cell-based ELISA
type of assay or intracellularly by Western blotting.
However, the tag was not used in this study at this
stage. Constructs of the series C and D differ by the
presence of the lamprey (series C) or rat (series D)
ED (including SSD) upstream of all four possible
combinations of the transmembrane and IDs.
The constructs of C and D series were used as
templates for synthesis of the chimeric receptors clas-
sified under the series E and F which were prepared
in order to test for the effect of the reciprocal ex-
change of the full or partial SSDs of lamprey GpH-R
I and rat LH-R on the ability of the constructs
to interact with and be activated by mammalian gly-
coprotein hormones.
The SSD or ‘hinge’ segment is present in all gly-
coprotein hormone receptors in between the leu rich
repeat domain (LRD) and the N-terminal end of the
TMD. This is a region of poorly defined structural
organization considered initially to be a mere flexible
arm linking the LRD and TMD. However, new ex-
perimental evidence (Moyle et al. 2004, 2005; Lin
et al. 2007) suggests that it contains functionally im-
portant residues, critically involved in the selective
interaction with the ligand and in signal transduc-
tion. The SSD contains the exon9/exon10 junction in
all GpH-Rs, as well as the exon10/exon11 junction in
luteinizing hormone receptors.
A detailed diagram of the rat and lamprey SSD is
presented in Fig. 4. Fragments of the chimeric recep-
tors from series C and D (domain swapped) were
spliced at the level of the LRD/SSD boundary
(more precisely eight residues upstream of the
N-terminal end of the SSD), of the exon9/exon10
junctions (rat, lamprey) and exon10/exon11 (rat)
junction. This resulted in six different combinations
of the SSD fragments inserted in the original eight
domain-swapped chimeras (Fig. 2E and F).
Estimation of the response of the GpH-R
chimeras to oLH and oTSH
The effects of ovine LH and ovine TSH were tested
using the constructs of the series A and B (Fig. 3).
Fig. 4 Details of the rat LH-R/lamprey GpH-R I chimeras SSD level junctions. Arrowed vertical lines mark the splicing sites between rat
LH-R and lamprey GpH-R I.
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The results were calculated as fold increase over the
corresponding values obtained when concentration
of stimulus was zero. This implies that the values
obtained here do not account correctly for the rela-
tive contribution of the constitutive activity over the
effect of exposure to the hormone. This can be no-
ticed for example in the case of the pRF8LF9 con-
struct (rat LHR with lamprey ID) where the effect
of the oLH is underestimated due to the high con-
stitutive activity of this chimera (see next section).
However, the results in this experiment indicate a
high response for the constructs containing the rat
ED and suggest that the presence of the lGpH-R I
signal peptide does not impair the activation of the
signal transduction by oLH treatment. The response
to the TSH treatment on the other hand was low for
Fig. 5 Analysis of constitutive activity of rat LH-R/lamprey GpH-R I chimeric receptors series C–F (Fig. 2) in COS-7 cells. The chimeras
of the series C and D (ED, TMD, and ID domain-swap experiment are marked by open squares (pRF1 construct is the intact rat LH-R,
pRF2LF3 is the intact lamprey GpH-R 1 with the rat signal peptide). The units are fold increase over the response to 5 mM forskolin
treatment of the same culture, and same transfection, expressed as means SEM. The asterisks mark the values significantly different
from blank (pCRE-SEAPþ pcDNA3.1).
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all constructs so this ligand was not used in the next
steps.
Analysis of the constitutive activity
The constructs of the series C to D (FLAG contain-
ing chimeras), D and F (SSD modified chimeras)
were used for assessment of the constitutive activity
in COS-7 cells. Figure 5 shows the SEAP activities in
the culture media at concentration of ligand equal
to zero, normalized in respect to the response to
forskolin 5 mM treatment in the same experiment.
Three constructs showed a significantly (P50.05)
higher constitutive activity compared with both con-
stitutive activity of lGpH-R I (pRF2LF3 construct)
and rLH-R (pRF1 construct): pCF40CF20 (rat
LH-R with lamprey SSD and ID), pCF40LF13 (lam-
prey GpH-R I with rat ED) and pRF8LF9_FLAG (rat
LH-R with lamprey ID).
Response to treatment with ovine LH, human FSH,
human CG, and PMSG
Figures 6 and 7 show the dose/response curves ob-
tained by treatment of each of the chimeric con-
structs from series C and D with four glycoprotein
hormones (ovine luteinizing hormone, oLH; human
chorionic gonadotropin, hCG; human follicle stimu-
lating hormone, hFSH; and pregnant mare serum
gonadotropin, PMSG).
Fig. 6 cAMP response of domain-swapped rat LH-R/lamprey GpH-R I chimeras (series C, lamprey ED) to oLH, hFSH, hCG, and PMSG
in COS-7 cells.
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Analysis of series C (with lamprey ED) chimeras
did not result in a significant response for any of the
hormones tested with one exception: the response
of the pCF3CF2_FLAG construct (lamprey GpH-R
I with rat TMD) to luteinizing hormone oLH stim-
ulation. Receptors of the series D (rat ED) resulted
in a high signal detected in response to stimulation
with any of oLH, hCG, and PMSG hormones.
The follicle stimulating hormone hFSH was inac-
tive with the exception of one construct, pRF8LF9_
FLAG (rat LH-R with lamprey ID) for which a signal
almost as high as for hCG and PMSG was detected.
Effect of SSDmodification on the response to
ovine LH treatment
Twenty-three lamprey/rat chimeras were prepared by
reciprocal exchanges of the fragments of the SSD
segment of both receptors applied to each of the
constructs in series C and D. These constructs were
then used for screening the change in their response
upon exposure of the transfected cells to mammalian
(ovine) LH. Only the most significant results are re-
ported here. Insertion of the rat SSD in the wild-type
lGpH-R I resulted in increased response to hormone
treatment (Fig. 8, left panel, pCF36CF23). This
Fig. 7 cAMP response of domain-swapped rat LH-R/lamprey GpH-R I chimeras (series D, rat ED) to oLH, hFSH, hCG, and PMSG in
COS-7 cells.
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increase was lost when the N-terminal fragment of
lamprey SSD (see Fig. 4) replaced the corresponding
region of the rat SSD (pCF37CF29). The responsive-
ness of the construct to oLH was restored after re-
moval of the rat fragment corresponding to exon 10
(pCF38CF32), this chimera inducing an even higher
stimulation of SEAP secretion than the rat SSD only
receptor at higher concentrations of ligand.
A similar pattern was observed when the same
manipulations of the SSD were applied to the lam-
prey ED/rat TMD hybrid (Fig. 8, right panel): inser-
tion of the rat SSD upstream of the rat TMD
(pCF36CF24) resulted in increased response of
the chimera to treatment with oLH. Replacement
of N-terminal fragment with lamprey sequence
(pCF37CF30) resulted in an unresponsive construct.
Further elimination of the 10th exon sequence of rat
(pCF38CF33) restored the activation of the construct
at even higher levels.
Discussion
Construction of chimeric proteins is an experimental
tool that is widely used in the study of functional prop-
erties of glycoprotein hormone receptors. This ap-
proach was particularly effective in identification
and localization of the structural determinants of the
ligand binding selectivity among thyrotropin, lutropin
and follitropin members of this subfamily of receptors
(Dufau 1998; Ascoli et al. 2002; Costagliola et al. 2005;
Moyle et al. 2005). Depending on the specifics of the
experimental designs applied, smaller or larger frag-
ments of one receptor are inserted into a second one
and the properties of the new construct are evaluated
by different experimental methods in respect to the
properties of the original proteins as a reference.
Application of this methodology to investigate the
functional divergence between a lamprey GpH-R
(lGpH-R I) and a mammalian (rat) GpH-R (rLH-R)
resulted in identification of specific combination of
domains exhibiting functional properties which are
distinct from their parent receptors (lamprey and
rat) in respect to both ligand selectivity and constitu-
tive activity. This suggests that evolutionary change at
the level of individual domains did not alter funda-
mentally their original functions, but receptor selectiv-
ities have been refined by subtle correlated changes in
multiple domains under the specific constraint of
binding of increasingly divergent ligands.
Although not always explicitly stated, this experi-
mental approach is based on an assumption of a
non-random effect of the transfer of a particular pro-
tein fragment from one molecule to another, i.e., on
an assumption of functional homology between the
protein segments under investigation. This relies ul-
timately on the concept of the proteins as strings
of domains, each domain being a functional unit,
exposed to specific evolutionary constraints. In
the case of the GpH-R subfamily of receptors, the
main structural/functional units usually characterized
are the ED, the TMD, and the ID. Their functions
are, respectively, the binding of the ligand, the trans-
fer of signal to the intracellular medium, and the
regulation of silencing and internalization of the
receptor.
Experimental evidence collected especially in the
past decade suggested a finer functional specialization
Fig. 8 Effect of SSD manipulation on the cAMP response of chimeras containing lamprey ED to oLH stimulation in COS-7 cells.
Diagrams of the chimeric receptors are represented above the dose-response plots.
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within these broader structural units, leading to iden-
tification of the roles of conserved residues within the
leu rich repeat domain (LRD) (Smits et al. 2003) and
the cys rich boxes 1, 2, and 3 (Bonomi et al. 2006).
Moreover, the formerly neglected, poorly conserved,
low complexity or intrinsically disordered regions of
proteins have received new attention after the collec-
tion of experimental evidence indicating that these
regions may play an important role in the protein
function both in general (Chen et al. 2006) or in the
particular case of the LRD/TMD linker of GpH-Rs
(Bernard et al. 1998; Moyle et al. 2004). Lamprey
GpH-R is the most distant member of the vertebrate
group of glycoprotein hormone receptors identified to
date (Freamat and Sower 2008b). A glycoprotein hor-
mone beta chain was also described in lamprey and its
properties are being investigated but no data are avail-
able at this point on the binding to lGpH-R I or on
activation of signal transduction (Sower et al. 2006).
The lGpH-R I domains were assigned based on a mul-
tiple alignment with the vertebrate FSH-Rs, LH-Rs,
and TSH-Rs, but the only support for their putative
roles is the similarity scores with homologous regions
of vertebrate GpH-Rs (Freamat et al. 2006). The iden-
tity scores between lamprey and rat domains are as
follows: 40% for LRD [comparable with the identity
scores calculated between members of the vertebrate
GpH-Rs which varies between 39 and 46% (135)],
25% for SSD (low identity score but one of the highest
found between lGpH-R I and all other vertebrate
GpH-Rs), 67% for TMD (again, comparable with ver-
tebrate scores 68–72%), and 20% for ID (the most
divergent segment) (Freamat and Sower 2008b).
Given the lack of mechanistic data for lGpH-R
activity and the large evolutionary distance separat-
ing them, it is difficult to draw an uncontroversial
parallel between the functions of the similar sequence
segments of these two receptors. Moreover, the pos-
sibility exists that the chimeric receptors exhibit new
emergent properties, not directly related to the prop-
erties of the parent receptors, properties resulting
from novel chains of interactions between residues
and domains put in close proximity for the first
time (Campbell et al. 1997). Taking into account
these factors, we attempt to interpret the effects of
glycoprotein hormones on the chimeric lamprey/rat
receptors in three respects: (i) as indicative of the
functional roles of the lamprey GpH-R I segments
formally identified, based on their similarity scores
in the MSA, (ii) as providing further mechanistic
information in respect to the roles of the rat LH-R
domains, and (iii) as emergent properties, uniquely
characteristic to the respective lamprey/rat combina-
tion of domains.
The traditional concept on the mechanism of
ligand binding and signal transduction (Model A)
assigns distinct roles to the extracellular and TMDs
of the GpH-Rs. The ligand contacts both the ED at
the level of the Leu rich repeat (LRD) and the TMD
at the level of extracellular loops 2 and 3. The spe-
cificity of interaction is encoded in a small number
of residues located on the internal face of the
horseshoe-shaped LRD reviewed by Dufau (1998)
and Fan and Hendrickson (2005).
Identification of naturally occurring mutations in
the TMD of human FSH-R resulting in an increased
sensitivity of the receptor to hCG challenged the
common understanding of the role of the serpentine
region in the mechanisms determining the specificity
of interaction of glycoprotein hormone receptors
with the cognate ligands. The signal transduction ac-
tivity of the receptor (TSH-R then extended to all
GpH-Rs) is inhibited by the ED in the absence of the
ligand (Model B) (Vlaeminck-Guillem et al. 2002).
The specific binding of the ligand induces a confor-
mational change in the LRD which, in turn, results
in activation of the signal transduction via interac-
tion with the extracellular loops of the TMD. The
specificity in this model is also encoded in the ED.
However, this model does not require direct interac-
tion between the ligand and the TMD (Costagliola
et al. 2005). A third model of the specificity of acti-
vation of GpH-Rs by their ligands (Model C)
(Bernard et al. 1998; Moyle et al. 2004, 2005) also
indicates the Leu rich repeat domain as the primary
site for binding of hormone but instead of restrain-
ing the specificity determinants to the LRD (as in
Model A) or delegating the specificity of activation
to a ‘locked’ state of the TMD (as in Model B), it
describes the LRD, ‘hinge’ and TMD as an integrated
functional unit, the selectivity of the receptor being
the result of complex interactions between these
three structural units and the ligand during binding
and activation of the receptor. The ED/TMD linker
segment is identified in this case as a SSD.
Response of chimeric receptors to gonadotropin
and thyrotropin
In this experiment a preliminary cAMP signal-
transduction assay was performed in order to screen
for gonadotropin/thyrotropin response of domain-
swapped constructs. Half of the constructs have
the lamprey signal peptide at the N-terminal end.
Constitutive activity profile of chimeric receptors
suggests a role of the LRDþ SSD unit in modulating
the intrinsic constitutively activated state of the
TMD. The constitutive (basal) activation of cAMP
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pathways by the ligand-free receptor is the result of
the TMD being locked in an activated state in the
absence of the ligand. The basal activity of wild-type
constructs pRF1 (rLH-R) and pRF2LF3 (lGpH-R I)
show low levels, if any. The results in this experiment
can be summarized as follows: (i) lID induces in-
creased constitutive activity in rLH-R; (ii) the con-
comitant presence of the ID and SSD segments of the
lamprey in rat receptor seems to act synergistically
to induce a very high level of basal activity; and
(iii) this effect seems to be dependent primarily on
the presence of the rat ED.
Analysis of domain-swapped mutant response to
gonadotropins indicates a role of the TMD in ligand
selectivity mechanisms. All chimeras were modified
to include the rat signal peptide at the end of the
N-terminal to ensure the homogeneity of protein ex-
pression on the surface of the cell. Four gonadotro-
pin hormones were used in the cAMP assay in order
to test for the changes in selectivity of binding and
activation by gonadotropins of domain-swapped re-
ceptors. Insertion of the rat TMD into the wild-type
lamprey receptor resulted in increased sensitivity to
LH only. Presence of the lID downstream of the rat
LRDþ SSDþTMD combination altered the selectiv-
ity of the construct in respect to follitropin.
The rat SSD is capable of transferring the sensi-
tivity to lutropin in the lamprey receptor. The pres-
ence of the rat exon 10 inhibits the activating effect
of the lamprey N-terminal SSDþ rat C-terminal
SSD. In the last series of experiments, the effect of
different reciprocal exchanges at the level SSD
(‘hinge’) fragments of lGpHR-I and rLH-R on the
response to mammalian lutropin was measured in
an attempt to determine the possible role of this
region in receptor lGpH-R I selectivity. Exon 10 is
dispensable for the binding of hCG by hLH-R
(Ascoli et al. 2002).
In summary, the results indicate that although the
lamprey GpH-R I shows a low capability to be acti-
vated by a tetrapod gonadotropin (oLH), replace-
ment of the C-terminal half of its SSD with its rat
counterpart drastically changes its responsiveness to
oLH treatment. This indicates that the functionality
of the glycoprotein hormone receptors was remark-
ably well conserved in spite of the hundreds of mil-
lions of years of divergent evolution.
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